Burkholderia cepacia complex Phage-Antibiotic Synergy (PAS): antibiotics stimulate lytic phage activity.
about
Burkholderia cepacia Complex Vaccines: Where Do We Go from here?Three New Escherichia coli Phages from the Human Gut Show Promising Potential for Phage TherapySynergistic Interaction Between Phage Therapy and Antibiotics Clears Pseudomonas Aeruginosa Infection in Endocarditis and Reduces Virulence.Targeting Enterococcus faecalis biofilms with phage therapy.P1 Ref Endonuclease: A Molecular Mechanism for Phage-Enhanced Antibiotic Lethality.The Microbiome in Cystic Fibrosis.Parasites and competitors suppress bacterial pathogen synergistically due to evolutionary trade-offs.Characterization of novel Staphylococcus aureus lytic phage and defining their combinatorial virulence using the OmniLog® system.Modification of Escherichia coli-bacteriophage interactions by surfactants and antibiotics in vitro.Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing.Delivering phage therapy per os: benefits and barriers.The temperate Burkholderia phage AP3 of the Peduovirinae shows efficient antimicrobial activity against B. cenocepacia of the IIIA lineage.Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches.A Genotypic Analysis of Five P. aeruginosa Strains after Biofilm Infection by Phages Targeting Different Cell Surface Receptors.Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis Patients."French Phage Network"-Second Meeting ReportEnhancing Whole Phage Therapy and Their Derived Antimicrobial Enzymes through Complex Formulation.Selection of Potential Therapeutic Bacteriophages that Lyse a CTX-M-15 Extended Spectrum β-Lactamase Producing Salmonella enterica Serovar Typhi Strain from the Democratic Republic of the Congo.Rapid evolution of generalized resistance mechanisms can constrain the efficacy of phage-antibiotic treatmentsResistance Development to Bacteriophages Occurring during Bacteriophage TherapyStandardization of Larvae to Provide Reliable and Reproducible Results in the Study of Fungal Pathogens
P2860
Q26752346-F6BDDCF0-5B06-4793-943F-69A49513EDD3Q28550170-66E91A8B-F4B7-4B91-98AD-0A114ED497A1Q33553795-535B17F9-5685-4D53-9379-643C62082BDAQ35221145-711CA436-1035-4577-BB5C-B914AED9A113Q35893892-3CCA6D11-4710-43DB-8127-6793E634B3D9Q35917770-83A368EC-9DDF-4C7F-B751-27A42693F86DQ36214728-D025369A-4640-4DCF-BED0-C3CC6D634F26Q37324738-03A7EC8C-8887-4289-892E-36E667EE0B9AQ37387916-A08742FA-D8C3-454F-8848-A852E6788B3DQ38686917-60287747-B48B-4E1B-B19D-213669976340Q39019401-028C3438-6457-4C54-9342-9D3E5A683CFDQ39259998-AAB0CA88-F03E-4D2C-BFF5-94F48484E2D3Q40054770-AC0FFF44-D7E2-4FC9-A2C0-10F2B3DE2E36Q40120799-E9408D50-1BF2-4629-8D16-C1665807D4A7Q40306418-2CC8CC01-2EC7-4691-9902-30BF6C6F1E5CQ42357412-F6DA00F4-6905-4038-8893-AC987E87F72CQ52315864-DE40B192-2901-4B0C-AEC2-28EA7A908421Q54242866-7E3E50D6-4EA5-4CF3-A5A5-A62B58DB9E84Q57825242-863A4CB1-BA56-4663-82D4-748965703999Q57940652-84957298-D8D1-4CD3-B9A0-FF7A0272F797Q58761035-15EF561C-CDBF-42D3-B92F-B7A155979453
P2860
Burkholderia cepacia complex Phage-Antibiotic Synergy (PAS): antibiotics stimulate lytic phage activity.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Burkholderia cepacia complex P ...... timulate lytic phage activity.
@ast
Burkholderia cepacia complex P ...... timulate lytic phage activity.
@en
Burkholderia cepacia complex Phage-Antibiotic Synergy
@nl
type
label
Burkholderia cepacia complex P ...... timulate lytic phage activity.
@ast
Burkholderia cepacia complex P ...... timulate lytic phage activity.
@en
Burkholderia cepacia complex Phage-Antibiotic Synergy
@nl
prefLabel
Burkholderia cepacia complex P ...... timulate lytic phage activity.
@ast
Burkholderia cepacia complex P ...... timulate lytic phage activity.
@en
Burkholderia cepacia complex Phage-Antibiotic Synergy
@nl
P2860
P356
P1476
Burkholderia cepacia complex P ...... stimulate lytic phage activity
@en
P2093
Fatima Kamal
P2860
P304
P356
10.1128/AEM.02850-14
P407
P577
2014-12-01T00:00:00Z